{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T21:27:48Z","timestamp":1793050068672,"version":"4.5.0"},"reference-count":50,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","journal-of-hepatology.eu","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Hepatology"],"published-print":{"date-parts":[[2021,3]]},"DOI":"10.1016\/j.jhep.2020.11.027","type":"journal-article","created":{"date-parts":[[2020,11,25]],"date-time":"2020-11-25T11:22:36Z","timestamp":1606303356000},"page":"734-741","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":41,"title":["Changing epidemiology, implications, and recommendations for hepatitis C in women of childbearing age and during pregnancy"],"prefix":"10.1016","volume":"74","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6663-6253","authenticated-orcid":false,"given":"Tatyana","family":"Kushner","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2290-4580","authenticated-orcid":false,"given":"Nancy","family":"Reau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"7","key":"10.1016\/j.jhep.2020.11.027_bib1","doi-asserted-by":"crossref","first-page":"e0235715","DOI":"10.1371\/journal.pone.0235715","article-title":"The Hep-CORE policy score: a European hepatitis C national policy implementation ranking based on patient organization data","volume":"15","author":"Palayew","year":"2020","journal-title":"PLoS One"},{"issue":"8","key":"10.1016\/j.jhep.2020.11.027_bib2","doi-asserted-by":"crossref","first-page":"e186371","DOI":"10.1001\/jamanetworkopen.2018.6371","article-title":"Prevalence of hepatitis C virus infection in US States and the District of Columbia, 2013 to 2016","volume":"1","author":"Rosenberg","year":"2018","journal-title":"JAMA Netw Open"},{"issue":"4","key":"10.1016\/j.jhep.2020.11.027_bib3","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1111\/jvh.12481","article-title":"Hepatitis C virus seroprevalence in adults in Africa: a systematic review and meta-analysis","volume":"23","author":"Riou","year":"2016","journal-title":"J\u00a0Viral Hepat"},{"issue":"1","key":"10.1016\/j.jhep.2020.11.027_bib4","doi-asserted-by":"crossref","first-page":"e76","DOI":"10.1016\/S2214-109X(19)30462-0","article-title":"Associations between national development indicators and the age profile of people who inject drugs: results from a global systematic review and meta-analysis","volume":"8","author":"Hines","year":"2020","journal-title":"Lancet Glob Health"},{"issue":"11","key":"10.1016\/j.jhep.2020.11.027_bib5","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1016\/j.drugpo.2015.05.004","article-title":"Ten priorities for expanding access to HCV treatment for people who inject drugs in low- and middle-income countries","volume":"26","author":"Ford","year":"2015","journal-title":"Int J Drug Policy"},{"key":"10.1016\/j.jhep.2020.11.027_bib6","series-title":"Global Health Sector Strategy on Viral Hepatitis 2016\u20132021 Towards Ending Viral Hepatitis","year":"2016"},{"issue":"5","key":"10.1016\/j.jhep.2020.11.027_bib8","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/j.amepre.2018.05.029","article-title":"Hepatitis C virus in women of childbearing age, pregnant women, and children","volume":"55","author":"Schillie","year":"2018","journal-title":"Am J Prev Med"},{"issue":"28","key":"10.1016\/j.jhep.2020.11.027_bib9","doi-asserted-by":"crossref","first-page":"705","DOI":"10.15585\/mmwr.mm6528a2","article-title":"Increased hepatitis C virus (HCV) detection in women of childbearing age and potential risk for vertical transmission - United States and Kentucky, 2011-2014","volume":"65","author":"Koneru","year":"2016","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"11","key":"10.1016\/j.jhep.2020.11.027_bib10","doi-asserted-by":"crossref","first-page":"775","DOI":"10.7326\/M16-2350","article-title":"Hepatitis C virus infection among reproductive-aged women and children in the United States, 2006 to 2014","volume":"166","author":"Ly","year":"2017","journal-title":"Ann Intern Med"},{"issue":"8","key":"10.1016\/j.jhep.2020.11.027_bib11","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1038\/nrgastro.2017.100","article-title":"HCV elimination - lessons learned from a small Eurasian country, Georgia","volume":"14","author":"Nasrullah","year":"2017","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"10026","key":"10.1016\/j.jhep.2020.11.027_bib12","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1016\/S0140-6736(16)00619-X","article-title":"Public health and international drug policy","volume":"387","author":"Csete","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.jhep.2020.11.027_bib13","article-title":"Impact of COVID-19 on global hepatitis C elimination efforts","author":"Blach","year":"2020","journal-title":"J\u00a0Hepatol"},{"issue":"14","key":"10.1016\/j.jhep.2020.11.027_bib15","doi-asserted-by":"crossref","first-page":"2873","DOI":"10.1017\/S0950268817001947","article-title":"Current prevalence of chronic hepatitis B and C virus infection in the general population, blood donors and pregnant women in the EU\/EEA: a systematic review","volume":"145","author":"Hofstraat","year":"2017","journal-title":"Epidemiol Infect"},{"issue":"1","key":"10.1016\/j.jhep.2020.11.027_bib16","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/s40249-019-0526-8","article-title":"Gender development and hepatitis B and C infections among pregnant women in Africa: a systematic review and meta-analysis","volume":"8","author":"Bigna","year":"2019","journal-title":"Infect Dis Poverty"},{"issue":"2","key":"10.1016\/j.jhep.2020.11.027_bib17","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1097\/AOG.0000000000003644","article-title":"Reported prevalence of maternal hepatitis C virus infection in the United States","volume":"135","author":"Rossi","year":"2020","journal-title":"Obstet Gynecol"},{"issue":"39","key":"10.1016\/j.jhep.2020.11.027_bib18","doi-asserted-by":"crossref","first-page":"833","DOI":"10.15585\/mmwr.mm6839a1","article-title":"National trends in hepatitis C infection by opioid use disorder status among pregnant women at delivery hospitalization - United States, 2000-2015","volume":"68","author":"Ko","year":"2019","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"3","key":"10.1016\/j.jhep.2020.11.027_bib19","doi-asserted-by":"crossref","first-page":"313","DOI":"10.17219\/acem\/76739","article-title":"Hepatitis C infection among pregnant women in central Poland: significance of epidemiological anamnesis and impact of screening tests to detect infection","volume":"28","author":"Aniszewska","year":"2019","journal-title":"Adv Clin Exp Med"},{"issue":"2","key":"10.1016\/j.jhep.2020.11.027_bib21","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1007\/s10995-019-02841-1","article-title":"Estimates of prenatal HIV, hepatitis B virus, and hepatitis C virus testing among pregnant people enrolled in Wisconsin Medicaid, 2011-2015","volume":"24","author":"Watts","year":"2020","journal-title":"Matern Child Health J"},{"issue":"9","key":"10.1016\/j.jhep.2020.11.027_bib22","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1055\/s-0039-3402753","article-title":"Effect of needle exchange program on maternal hepatitis C virus prevalence","volume":"37","author":"Rossi","year":"2020","journal-title":"Am J Perinatol"},{"issue":"7","key":"10.1016\/j.jhep.2020.11.027_bib23","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1111\/tmi.13404","article-title":"Micro-elimination of hepatitis C through testing of Egyptian pregnant women presenting at delivery: implications for screening policies","volume":"25","author":"Mostafa","year":"2020","journal-title":"Trop Med Int Health"},{"issue":"7","key":"10.1016\/j.jhep.2020.11.027_bib24","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1016\/j.jfma.2020.04.002","article-title":"2020 Taiwan consensus statement on the management of hepatitis C: part (II) special populations","volume":"119","author":"Yu","year":"2020","journal-title":"J\u00a0Formos Med Assoc"},{"key":"10.1016\/j.jhep.2020.11.027_bib25","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.ejogrb.2020.09.023","article-title":"Serological screening for hepatitis C during pregnancy: seroprevalence and maternal and neonatal outcomes in 45,000 pregnant women","volume":"254","author":"Piffer","year":"2020","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"issue":"3","key":"10.1016\/j.jhep.2020.11.027_bib27","doi-asserted-by":"crossref","first-page":"e200538","DOI":"10.1001\/jamanetworkopen.2020.0538","article-title":"USPSTF's hepatitis C screening recommendation-a necessary Step to tackling an evolving epidemic","volume":"3","author":"Rosenberg","year":"2020","journal-title":"JAMA Netw Open"},{"issue":"2","key":"10.1016\/j.jhep.2020.11.027_bib28","doi-asserted-by":"crossref","first-page":"1","DOI":"10.15585\/mmwr.rr6902a1","article-title":"CDC recommendations for hepatitis C screening among adults - United States, 2020","volume":"69","author":"Schillie","year":"2020","journal-title":"MMWR Recomm Rep"},{"issue":"11","key":"10.1016\/j.jhep.2020.11.027_bib29","doi-asserted-by":"crossref","first-page":"1888","DOI":"10.1093\/cid\/ciz063","article-title":"Cost-effectiveness of universal hepatitis C virus screening of pregnant women in the United States","volume":"69","author":"Chaillon","year":"2019","journal-title":"Clin Infect Dis"},{"issue":"2","key":"10.1016\/j.jhep.2020.11.027_bib30","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1097\/AOG.0000000000003062","article-title":"Short-term effects and long-term cost-effectiveness of universal hepatitis C testing in prenatal care","volume":"133","author":"Tasillo","year":"2019","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.jhep.2020.11.027_bib33","article-title":"Cost-effectiveness of antenatal rescreening among pregnant women for hepatitis C in the United States","author":"Chaillon","year":"2020","journal-title":"Clin Infect Dis"},{"issue":"2","key":"10.1016\/j.jhep.2020.11.027_bib34","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/j.jhep.2018.03.026","article-title":"EASL recommendations on treatment of hepatitis C 2018","volume":"69","year":"2018","journal-title":"J\u00a0Hepatol"},{"issue":"5","key":"10.1016\/j.jhep.2020.11.027_bib35","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1007\/s12072-016-9736-3","article-title":"APASL consensus statements and recommendations for hepatitis C prevention, epidemiology, and laboratory testing","volume":"10","author":"Omata","year":"2016","journal-title":"Hepatol Int"},{"issue":"6","key":"10.1016\/j.jhep.2020.11.027_bib36","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1093\/cid\/ciu447","article-title":"Vertical transmission of hepatitis C virus: systematic review and meta-analysis","volume":"59","author":"Benova","year":"2014","journal-title":"Clin Infect Dis"},{"issue":"1","key":"10.1016\/j.jhep.2020.11.027_bib37","first-page":"52","article-title":"Vertical transmission of hepatitis C: towards universal antenatal screening in the era of new direct acting antivirals (DAAs)? Short review and analysis of the situation in Switzerland","volume":"2","author":"Aebi-Popp","year":"2016","journal-title":"J\u00a0Virus Erad"},{"key":"10.1016\/j.jhep.2020.11.027_bib38","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.jcv.2015.04.002","article-title":"Low mother-to-child-transmission rate of hepatitis C virus in cART treated HIV-1 infected mothers","volume":"68","author":"Snijdewind","year":"2015","journal-title":"J\u00a0Clin Virol"},{"issue":"2","key":"10.1016\/j.jhep.2020.11.027_bib39","doi-asserted-by":"crossref","first-page":"e00379","DOI":"10.1002\/prp2.379","article-title":"Race affects SVR12 in a large and ethnically diverse hepatitis C-infected patient population following treatment with direct-acting antivirals: analysis of a single-center Department of Veterans Affairs cohort","volume":"6","author":"Benhammou","year":"2018","journal-title":"Pharmacol Res Perspect"},{"key":"10.1016\/j.jhep.2020.11.027_bib40","article-title":"Nucleic Acid testing for diagnosis of perinatally-acquired hepatitis C virus infection in early infancy","author":"Gowda","year":"2020","journal-title":"Clin Infect Dis"},{"issue":"4","key":"10.1016\/j.jhep.2020.11.027_bib41","doi-asserted-by":"crossref","first-page":"e0230109","DOI":"10.1371\/journal.pone.0230109","article-title":"Perinatal HCV transmission rate in HIV\/HCV coinfected women with access to ART in Madrid, Spain","volume":"15","author":"Dominguez-Rodriguez","year":"2020","journal-title":"PLoS One"},{"issue":"8","key":"10.1016\/j.jhep.2020.11.027_bib42","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1093\/cid\/ciw026","article-title":"Failure to test and identify perinatally infected children born to hepatitis C virus-infected women","volume":"62","author":"Kuncio","year":"2016","journal-title":"Clin Infect Dis"},{"issue":"6","key":"10.1016\/j.jhep.2020.11.027_bib43","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2017-3273","article-title":"Hepatitis C virus screening among children exposed during pregnancy","volume":"141","author":"Chappell","year":"2018","journal-title":"Pediatrics"},{"issue":"4","key":"10.1016\/j.jhep.2020.11.027_bib44","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1111\/liv.13146","article-title":"Prediction of HCV vertical transmission: what factors should be optimized using data mining computational analysis","volume":"37","author":"Elrazek","year":"2017","journal-title":"Liver Int"},{"issue":"2","key":"10.1016\/j.jhep.2020.11.027_bib45","doi-asserted-by":"crossref","first-page":"F156","DOI":"10.1136\/adc.2004.059436","article-title":"When does mother to child transmission of hepatitis C virus occur?","volume":"90","author":"Mok","year":"2005","journal-title":"Arch Dis Child Fetal Neonatal Ed"},{"issue":"2","key":"10.1016\/j.jhep.2020.11.027_bib47","doi-asserted-by":"crossref","first-page":"109","DOI":"10.7326\/0003-4819-158-2-201301150-00575","article-title":"Reducing risk for mother-to-infant transmission of hepatitis C virus: a systematic review for the U.S. Preventive Services Task Force","volume":"158","author":"Cottrell","year":"2013","journal-title":"Ann Intern Med"},{"issue":"5","key":"10.1016\/j.jhep.2020.11.027_bib48","doi-asserted-by":"crossref","first-page":"B2","DOI":"10.1016\/j.ajog.2017.07.039","article-title":"Hepatitis C in pregnancy: screening, treatment, and management","volume":"217","author":"Hughes","year":"2017","journal-title":"Am J Obstet Gynecol"},{"issue":"9","key":"10.1016\/j.jhep.2020.11.027_bib49","doi-asserted-by":"crossref","first-page":"643","DOI":"10.4254\/wjh.v6.i9.643","article-title":"Vertical transmission of hepatitis C virus: current knowledge and perspectives","volume":"6","author":"Yeung","year":"2014","journal-title":"World J Hepatol"},{"issue":"12","key":"10.1016\/j.jhep.2020.11.027_bib50","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1111\/jvh.12430","article-title":"Chronic hepatitis C virus infection is associated with increased risk of preterm birth: a meta-analysis of observational studies","volume":"22","author":"Huang","year":"2015","journal-title":"J\u00a0Viral Hepat"},{"issue":"7","key":"10.1016\/j.jhep.2020.11.027_bib51","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1007\/s10654-017-0261-z","article-title":"Pregnancy outcome in more than 5000 births to women with viral hepatitis: a population-based cohort study in Sweden","volume":"32","author":"Stokkeland","year":"2017","journal-title":"Eur J Epidemiol"},{"issue":"4","key":"10.1016\/j.jhep.2020.11.027_bib52","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1002\/hep.26444","article-title":"Intrahepatic cholestasis of pregnancy and associated hepatobiliary disease: a population-based cohort study","volume":"58","author":"Marschall","year":"2013","journal-title":"Hepatology"},{"issue":"1","key":"10.1016\/j.jhep.2020.11.027_bib53","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.clinre.2016.07.004","article-title":"Hepatitis C infection and intrahepatic cholestasis of pregnancy: a systematic review and meta-analysis","volume":"41","author":"Wijarnpreecha","year":"2017","journal-title":"Clin Res Hepatol Gastroenterol"},{"issue":"10174","key":"10.1016\/j.jhep.2020.11.027_bib54","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1016\/S0140-6736(18)31877-4","article-title":"Association of adverse perinatal outcomes of intrahepatic cholestasis of pregnancy with biochemical markers: results of aggregate and individual patient data meta-analyses","volume":"393","author":"Ovadia","year":"2019","journal-title":"Lancet"},{"issue":"11","key":"10.1016\/j.jhep.2020.11.027_bib55","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1002\/hep4.1264","article-title":"Evaluating women's preferences for hepatitis C treatment during pregnancy","volume":"2","author":"Kushner","year":"2018","journal-title":"Hepatol Commun"},{"issue":"6","key":"10.1016\/j.jhep.2020.11.027_bib58","doi-asserted-by":"crossref","first-page":"1656","DOI":"10.1002\/hep.28032","article-title":"HCV vertical transmission in pregnancy: new horizons in the era of DAAs","volume":"62","author":"Kanninen","year":"2015","journal-title":"Hepatology"},{"issue":"5","key":"10.1016\/j.jhep.2020.11.027_bib59","doi-asserted-by":"crossref","first-page":"e200","DOI":"10.1016\/S2666-5247(20)30062-8","article-title":"Ledipasvir plus sofosbuvir in pregnant women. with hepatitis C virus infection: a phase 1 pharmacokinetic study","volume":"1","author":"Chappell","year":"2020","journal-title":"Lancet Microbe"}],"container-title":["Journal of Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168827820338149?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168827820338149?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T19:42:45Z","timestamp":1759174965000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168827820338149"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3]]},"references-count":50,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2021,3]]}},"alternative-id":["S0168827820338149"],"URL":"https:\/\/doi.org\/10.1016\/j.jhep.2020.11.027","relation":{},"ISSN":["0168-8278"],"issn-type":[{"value":"0168-8278","type":"print"}],"subject":[],"published":{"date-parts":[[2021,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Changing epidemiology, implications, and recommendations for hepatitis C in women of childbearing age and during pregnancy","name":"articletitle","label":"Article Title"},{"value":"Journal of Hepatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jhep.2020.11.027","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 European Association for the Study of the Liver. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}